Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

ELTX holding history

Elicio Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELTX overviewAll 13F holders of ELTXFull Q2 2026 holdings

Shares (Q2 2026)
25,546
Value
$99.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELTX by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202625,546$99.9K<0.1%−6,858−21.2%ReducedHolders
Q1 202632,404$346.4K<0.1%+17,851+122.7%AddedHolders
Q4 202514,553$115.8K<0.1%+13,017+847.5%AddedHolders
Q3 20251,536$16.8K<0.1%+1,156+304.2%AddedHolders
Q2 2025380$2.93K<0.1%−462−54.9%ReducedHolders
Q1 2025842$5.19K<0.1%+612+266.1%AddedHolders
Q4 2024230$1.17K<0.1%−10−4.2%ReducedHolders
Q3 2024240$1.21K<0.1%+10+4.3%AddedHolders
Q2 2024230$945<0.1%+100+76.9%AddedHolders
Q1 2024130$988<0.1%−27−17.2%ReducedHolders
Q4 2023157$1.31K<0.1%00.0%UnchangedHolders
Q3 2023157$1.33K<0.1%+30+23.6%AddedHolders
Q2 2023127$1.21K<0.1%−285−69.2%ReducedConverted for a 1-for-10 splitHolders
Q1 20234,120$2.39K<0.1%−666−13.9%ReducedHolders
Q4 20224,786$3.88K<0.1%−1,618−25.3%ReducedHolders
Q3 20226,404$5.00K<0.1%−10,852−62.9%ReducedHolders
Q2 202217,256$20.0K<0.1%−107,970−86.2%ReducedHolders
Q1 2022125,226$266.0K<0.1%−36,008−22.3%ReducedHolders
Q4 2021161,234$468.0K<0.1%+121,781+308.7%AddedHolders
Q3 202139,453$385.0K<0.1%+12,057+44.0%AddedHolders
Q2 202127,396$357.0K<0.1%+26,449+2,792.9%AddedHolders
Q1 2021947$17.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.